{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:44:59Z","timestamp":1791402299912,"version":"4.3.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T00:00:00Z","timestamp":1416528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00277-014-2259-x","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T12:34:07Z","timestamp":1416573247000},"page":"663-669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic\/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation"],"prefix":"10.1007","volume":"94","author":[{"given":"Eolia","family":"Brissot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Cahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Delaunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Ayari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Peterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Le Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Harousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Bene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,21]]},"reference":[{"issue":"3","key":"2259_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","volume":"48","author":"D Neofytos","year":"2009","unstructured":"Neofytos D, Horn D, Anaissie E et al (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48(3):265\u2013273","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2259_CR2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","volume":"102","author":"T Fukuda","year":"2003","unstructured":"Fukuda T, Boeckh M, Carter RA et al (2003) Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102(3):827\u2013833","journal-title":"Blood"},{"issue":"8","key":"2259_CR3","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbmt.2013.05.018","volume":"19","author":"AK Omer","year":"2013","unstructured":"Omer AK, Ziakas PD, Anagnostou T et al (2013) Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. Biol Blood Marrow Transplant 19(8):1190\u20131196","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2259_CR4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50(8):1091\u20131100","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2259_CR5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bbmt.2004.06.003","volume":"10","author":"R Kojima","year":"2004","unstructured":"Kojima R, Kami M, Nannya Y et al (2004) Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen. Biol Blood Marrow Transplant 10(9):645\u2013652","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2259_CR6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/522189","volume":"45","author":"L Pagano","year":"2007","unstructured":"Pagano L, Caira M, Nosari A et al (2007) Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study\u2014Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 45(9):1161\u20131170","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2259_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11046-009-9196-6","volume":"168","author":"EJ Bow","year":"2009","unstructured":"Bow EJ (2009) Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician\u2019s viewpoint. Mycopathologia 168(6):283\u2013297","journal-title":"Mycopathologia"},{"issue":"13","key":"2259_CR8","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","volume":"100","author":"KA Marr","year":"2002","unstructured":"Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100(13):4358\u20134366","journal-title":"Blood"},{"issue":"6","key":"2259_CR9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","volume":"171","author":"MA Slavin","year":"1995","unstructured":"Slavin MA, Osborne B, Adams R et al (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study. J Infect Dis 171(6):1545\u20131552","journal-title":"J Infect Dis"},{"issue":"13","key":"2259_CR10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","volume":"326","author":"JL Goodman","year":"1992","unstructured":"Goodman JL, Winston DJ, Greenfield RA et al (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326(13):845\u2013851","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"2259_CR11","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.1093\/clinids\/12.Supplement_3.S267","volume":"12","author":"K Richardson","year":"1990","unstructured":"Richardson K, Cooper K, Marriott MS, Tarbit MH, Troke PF, Whittle PJ (1990) Discovery of fluconazole, a novel antifungal agent. Rev Infect Dis 12(Suppl 3):S267\u2013S271","journal-title":"Rev Infect Dis"},{"issue":"6","key":"2259_CR12","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","volume":"96","author":"KA Marr","year":"2000","unstructured":"Marr KA, Seidel K, Slavin MA et al (2000) Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 96(6):2055\u20132061","journal-title":"Blood"},{"issue":"5","key":"2259_CR13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","volume":"46","author":"J Maertens","year":"2011","unstructured":"Maertens J, Marchetti O, Herbrecht R et al (2011) European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update. Bone Marrow Transplant 46(5):709\u2013718","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2259_CR14","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1086\/605665","volume":"49","author":"C Girmenia","year":"2009","unstructured":"Girmenia C, Barosi G, Aversa F et al (2009) Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis 49(8):1226\u20131236","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2259_CR15","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/375088","volume":"36","author":"SB Mossad","year":"2003","unstructured":"Mossad SB, Avery RK, Bolwell BJ (2003) Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant. Clin Infect Dis 36(11):1503\u20131504, author reply 1504","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2259_CR16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1703230","volume":"28","author":"JE Johansson","year":"2001","unstructured":"Johansson JE, Brune M, Ekman T (2001) The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning. Bone Marrow Transplant 28(8):737\u2013742","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2259_CR17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S1470-2045(12)70349-2","volume":"13","author":"M Bornhauser","year":"2012","unstructured":"Bornhauser M, Kienast J, Trenschel R et al (2012) Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. Lancet Oncol 13(10):1035\u20131044","journal-title":"Lancet Oncol"},{"issue":"3","key":"2259_CR18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/bmt.2008.313","volume":"43","author":"V Bachanova","year":"2009","unstructured":"Bachanova V, Brunstein CG, Burns LJ et al (2009) Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma. Bone Marrow Transplant 43(3):237\u2013244","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2259_CR19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1182\/blood-2005-11-4503","volume":"108","author":"R Martino","year":"2006","unstructured":"Martino R, Iacobelli S, Brand R et al (2006) Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood 108(3):836\u2013846","journal-title":"Blood"},{"issue":"5","key":"2259_CR20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbmt.2008.02.014","volume":"14","author":"M Tomblyn","year":"2008","unstructured":"Tomblyn M, Brunstein C, Burns LJ et al (2008) Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 14(5):538\u2013545","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"2259_CR21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"367","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ et al (2012) Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 367(16):1487\u20131496","journal-title":"N Engl J Med"},{"issue":"8","key":"2259_CR22","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/bmt.2011.246","volume":"47","author":"MC Arendrup","year":"2012","unstructured":"Arendrup MC, Bille J, Dannaoui E, Ruhnke M, Heussel CP, Kibbler C (2012) ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia. Bone Marrow Transplant 47(8):1030\u20131045","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2259_CR23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1703252","volume":"28","author":"A Safdar","year":"2001","unstructured":"Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J (2001) Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Bone Marrow Transplant 28(9):873\u2013878","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2259_CR24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN (2012) Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 50(4):1199\u20131203","journal-title":"J Clin Microbiol"},{"issue":"17\u201318","key":"2259_CR25","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1089\/ten.tea.2011.0131","volume":"17","author":"I Martin","year":"2011","unstructured":"Martin I, Baldomero H, Bocelli-Tyndall C, Slaper-Cortenbach I, Passweg J, Tyndall A (2011) The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng A 17(17\u201318):2221\u20132230","journal-title":"Tissue Eng A"},{"issue":"12","key":"2259_CR26","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D et al (2009) Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 15(12):1628\u20131633","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2259_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34(1):7\u201314","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2259_CR28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695\u2013706","journal-title":"Stat Med"},{"issue":"2","key":"2259_CR29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69(2):204\u2013217","journal-title":"Am J Med"},{"issue":"4","key":"2259_CR30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295\u2013304","journal-title":"Transplantation"},{"key":"2259_CR31","doi-asserted-by":"crossref","unstructured":"Ziakas PD, Kourbeti IS, Mylonakis E (2014) Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis. Clin Ther","DOI":"10.1016\/j.clinthera.2013.11.010"},{"issue":"9","key":"2259_CR32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1704889","volume":"35","author":"F Larosa","year":"2005","unstructured":"Larosa F, Marmier C, Robinet E et al (2005) Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation. Bone Marrow Transplant 35(9):859\u2013868","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2259_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/344906","volume":"36","author":"EA Hagen","year":"2003","unstructured":"Hagen EA, Stern H, Porter D et al (2003) High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation. Clin Infect Dis 36(1):9\u201315","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2259_CR34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","volume":"8","author":"C Junghanss","year":"2002","unstructured":"Junghanss C, Marr KA, Carter RA et al (2002) Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant 8(9):512\u2013520","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2259_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/tid.12003","volume":"15","author":"SH Kim","year":"2013","unstructured":"Kim SH, Kee SY, Lee DG et al (2013) Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens. Transpl Infect Dis 15(1):49\u201359","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"2259_CR36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1704662","volume":"34","author":"E Jantunen","year":"2004","unstructured":"Jantunen E, Nihtinen A, Volin L et al (2004) Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis. Bone Marrow Transplant 34(10):891\u2013895","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2259_CR37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH et al (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356(4):335\u2013347","journal-title":"N Engl J Med"},{"issue":"6","key":"2259_CR38","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.168.6.2904","volume":"168","author":"A Bacci","year":"2002","unstructured":"Bacci A, Montagnoli C, Perruccio K et al (2002) Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 168(6):2904\u20132913","journal-title":"J Immunol"},{"issue":"10","key":"2259_CR39","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1182\/blood-2003-03-0748","volume":"102","author":"S Bozza","year":"2003","unstructured":"Bozza S, Perruccio K, Montagnoli C et al (2003) A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102(10):3807\u20133814","journal-title":"Blood"},{"issue":"2","key":"2259_CR40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10428194.2010.542600","volume":"52","author":"CO Morrissey","year":"2011","unstructured":"Morrissey CO, Chen SC, Sorrell TC et al (2011) Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies. Leuk Lymphoma 52(2):179\u2013193","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2259-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2259-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2259-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T03:04:54Z","timestamp":1598497494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2259-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,21]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2259-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,21]]}}}